Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Diabetes

Journal Scan / Research · July 31, 2015

Impact of New Insulin Glargine 300 U/mL vs Glargine 100 U/mL on Glucose Control and Hypoglycemia in T2DM

Diabetes, Obesity & Metabolism

 

Additional Info

Disclosure statements are available on the authors' profiles:

Diabetes, Obesity & Metabolism
Glycaemic Control and Hypoglycaemia With New Insulin Glargine 300 U/mL Versus Glargine 100 U/mL in People With Type 2 Diabetes Using Basal Insulin and Oral Antihyperglycaemic Drugs (EDITION 2 Randomised 12-month Trial Including 6-month Extension)
Diabetes Obes Metab 2015 Jul 14;[EPub Ahead of Print], H Yki-Järvinen, RM Bergenstal, GB Bolli, M Ziemen, M Wardecki, I Muehlen-Bartmer, M Maroccia, MC Riddle

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading